TELA Bio Inc (TELA) Actualités

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Dec. 13, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a...

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical...

Form 8-K - Current report

TELA Bio Reports Third Quarter 2024 Financial Results

MALVERN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) --  TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical...

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Nov. 01, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

MALVERN, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

MALVERN, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical...

Form 424B5 - Prospectus [Rule 424(b)(5)]

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical...